Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have a condition called Barrett's oesophagus, where the lining of the food pipe has changed, measuring between 2 cm and 6 cm in length
- People whose Barrett's oesophagus has been confirmed by a tissue sample (biopsy) to have low to high grade cell changes (dysplasia), or who have had a very early, non-spreading cancer of the food pipe that has already been surgically removed
- People who have signed the consent form to take part in the study (note: signing consent can happen before the biopsy results are fully confirmed)
Who may not be able to join:
- People over 85 years of age
- Women who are pregnant, breastfeeding, or in labour
- People who are in detention by a court or government decision
- People receiving psychiatric treatment against their will
- People who are under a legal protection order
- People who are not able to give their own consent to participate
- People who do not understand French or are unable to read
- People who are not enrolled in or covered by a French social security scheme
- People who have active inflammation of the food pipe caused by stomach acid, radiation, or related complications at the time of treatment
- People who have a visible lesion in the food pipe that biopsies have confirmed to be cancer
- People who previously had a food pipe cancer removed by an endoscopic procedure where the cancer reached the edges of the removed tissue, or where the cancer was poorly formed or had spread more than 500 micrometres into the tissue layer beneath the surface lining (confirm with trial site)
- People who have previously had any ablation (tissue removal or destruction) treatment or a stretching procedure for a narrowed food pipe
- People with a significantly narrowed food pipe that cannot be passed through with a standard medical camera scope
- People with enlarged veins in the food pipe (varices) or high blood pressure in the liver's blood vessels (portal hypertension)
- People taking blood-thinning medications that cannot be safely stopped before the procedure (low-dose aspirin up to 100 mg per day on its own may be acceptable — confirm with trial site), or people with uncorrectable bleeding or clotting problems
- People for whom anaesthesia is medically not suitable
- People who are unable to take a type of stomach acid-reducing medication called proton pump inhibitors (PPIs) by mouth
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elodie CESBRON-METIVIER, Ph.D., UH Angers
Phone: +33241353148
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The rate of full eradication of Barrett esophagus (metaplasia), which is defined by the absence of residual Barrett esophagus in the check-up endocopy after 3 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.